Female Contraceptive Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Contraceptive Drugs, By Device, By Region & Competition, 2020-2030F

Description

The Global Female Contraceptive Market was valued at USD 15.01 billion in 2024 and is projected to witness strong growth with a CAGR of 6.24% through 2030F. This market includes a diverse range of products and devices designed to prevent unintended pregnancies and support reproductive autonomy for women. Contraceptive options include hormonal methods like pills, implants, and patches, as well as barrier methods, intrauterine devices (IUDs), and emergency contraceptives. The sector plays a key role in family planning, reducing maternal mortality, and supporting women's health globally. Growing awareness about reproductive health, increased healthcare accessibility, supportive government initiatives, and evolving social norms are propelling demand. According to the UNFPA's 2022 report, nearly 121 million unintended pregnancies occur globally each year, highlighting the critical need for effective contraceptive solutions. Innovation in product development and shifting cultural attitudes continue to strengthen market expansion worldwide.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 15.01 Billion
Market Size 2030	USD 21.41 Billion
CAGR 2025-2030	6.24%
Fastest Growing Segment	Sub-dermal Contraceptive Implants
Largest Market	North America

Key Market Drivers

Women's Empowerment

Women's empowerment is a major catalyst for growth in the female contraceptive market, influencing healthcare decision-making and reproductive autonomy. Educated and informed women are better equipped to make decisions regarding contraception that align with their health needs and personal circumstances. Greater empowerment improves access to healthcare services, prompting more women to utilize family planning clinics and seek out reliable contraceptive options. As economic independence grows, women are increasingly able to afford and prioritize contraceptive products and services. This economic and social empowerment drives demand, encouraging pharmaceutical companies to innovate and expand contraceptive offerings to meet diverse needs across different populations.

Key Market Challenges

Limited Access and Awareness

Limited access to and awareness of contraceptive options remains a major barrier in the global female contraceptive market, particularly in underprivileged and rural areas. Many women face financial, cultural, or geographic constraints that prevent them from obtaining reliable contraceptives. A lack of education and knowledge about available methods also contributes to low adoption rates. Addressing this challenge requires coordinated efforts by governments, NGOs, and international health organizations to expand education campaigns and improve access to family planning services. By empowering women with accurate information and affordable options, these initiatives aim to reduce disparities and foster informed reproductive choices.

Key Market Trends

Hormonal Contraceptives with Reduced Side Effects

A significant trend shaping the female contraceptive market is the development of hormonal contraceptives designed to minimize side effects. Manufacturers are investing in research to produce solutions that effectively prevent pregnancy while reducing issues such as mood changes, weight gain, and reduced libido. These innovations aim to enhance the user experience, making hormonal contraceptives more appealing and acceptable to a broader population. As awareness of long-term reproductive health grows, demand for safer, user-friendly options is driving the evolution of new-generation hormonal contraceptives with improved tolerability and efficacy.

Key Market Players

Bayer AG
Mayer Laboratories Inc
Pfizer Inc
Mylan Pharmaceuticals Inc
Teva Pharmaceutical Industries Ltd
Organon & Co.
Agile Therapeutics Inc
Lupin Pharmaceuticals Inc
The Female Health Company
FUJI LATEX CO.LTD.

Report Scope:

In this report, the Global Female Contraceptive Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Female Contraceptive Market, By Contraceptive Drugs:

Oral Contraceptives
Contraceptive Injections
Topical Contraceptives
Spermicides

Female Contraceptive Market, By Device:

Female Condoms
Diaphragms and Caps
Vaginal Rings
Contraceptive Sponges
Sub-dermal Contraceptive Implants
Intra Uterine Contraceptive Devices (IUCDs)
Others

Female Contraceptive Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Female Contraceptive Market.

Available Customizations:

Global Female Contraceptive market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Female Contraceptive Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Contraceptive Drugs (Oral Contraceptives, Contraceptive Injections, Topical Contraceptives, Spermicides)
- 5.2.2. By Device (Female Condoms, Diaphragms and Caps, Vaginal Rings, Contraceptive Sponges, Sub-dermal Contraceptive Implants, Intra Uterine Contraceptive Devices (IUCDs), Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Product Market Map
- 5.3.1. By Contraceptive Drugs
- 5.3.2. By Device
- 5.3.3. By Region

6. North America Female Contraceptive Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Contraceptive Drugs (Oral Contraceptives, Contraceptive Injections, Topical Contraceptives, Spermicides)
- 6.2.2. By Device (Female Condoms, Diaphragms and Caps, Vaginal Rings, Contraceptive Sponges, Sub-dermal Contraceptive Implants, Intra Uterine Contraceptive Devices (IUCDs), Others)
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Female Contraceptive Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Contraceptive Drugs
    - 6.3.1.2.2. By Device
- 6.3.2. Canada Female Contraceptive Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Contraceptive Drugs
    - 6.3.2.2.2. By Device
- 6.3.3. Mexico Female Contraceptive Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Contraceptive Drugs
    - 6.3.3.2.2. By Device

7. Europe Female Contraceptive Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Contraceptive Drugs (Oral Contraceptives, Contraceptive Injections, Topical Contraceptives, Spermicides)
- 7.2.2. By Device (Female Condoms, Diaphragms and Caps, Vaginal Rings, Contraceptive Sponges, Sub-dermal Contraceptive Implants, Intra Uterine Contraceptive Devices (IUCDs), Others)
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Female Contraceptive Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Contraceptive Drugs
    - 7.3.1.2.2. By Device
- 7.3.2. United Kingdom Female Contraceptive Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Contraceptive Drugs
    - 7.3.2.2.2. By Device
- 7.3.3. France Female Contraceptive Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Contraceptive Drugs
    - 7.3.3.2.2. By Device
- 7.3.4. Italy Female Contraceptive Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Contraceptive Drugs
    - 7.3.4.2.2. By Device
- 7.3.5. Spain Female Contraceptive Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Contraceptive Drugs
    - 7.3.5.2.2. By Device

8. Asia-Pacific Female Contraceptive Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Contraceptive Drugs (Oral Contraceptives, Contraceptive Injections, Topical Contraceptives, Spermicides)
- 8.2.2. By Device (Female Condoms, Diaphragms and Caps, Vaginal Rings, Contraceptive Sponges, Sub-dermal Contraceptive Implants, Intra Uterine Contraceptive Devices (IUCDs), Others)
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Female Contraceptive Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Contraceptive Drugs
    - 8.3.1.2.2. By Device
- 8.3.2. Japan Female Contraceptive Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Contraceptive Drugs
    - 8.3.2.2.2. By Device
- 8.3.3. India Female Contraceptive Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Contraceptive Drugs
    - 8.3.3.2.2. By Device
- 8.3.4. Australia Female Contraceptive Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Contraceptive Drugs
    - 8.3.4.2.2. By Device
- 8.3.5. South Korea Female Contraceptive Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Contraceptive Drugs
    - 8.3.5.2.2. By Device

9. South America Female Contraceptive Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Contraceptive Drugs (Oral Contraceptives, Contraceptive Injections, Topical Contraceptives, Spermicides)
- 9.2.2. By Device (Female Condoms, Diaphragms and Caps, Vaginal Rings, Contraceptive Sponges, Sub-dermal Contraceptive Implants, Intra Uterine Contraceptive Devices (IUCDs), Others)
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Female Contraceptive Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Contraceptive Drugs
    - 9.3.1.2.2. By Device
- 9.3.2. Argentina Female Contraceptive Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Contraceptive Drugs
    - 9.3.2.2.2. By Device
- 9.3.3. Colombia Female Contraceptive Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Contraceptive Drugs
    - 9.3.3.2.2. By Device

10. Middle East and Africa Female Contraceptive Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Contraceptive Drugs (Oral Contraceptives, Contraceptive Injections, Topical Contraceptives, Spermicides)
- 10.2.2. By Device (Female Condoms, Diaphragms and Caps, Vaginal Rings, Contraceptive Sponges, Sub-dermal Contraceptive Implants, Intra Uterine Contraceptive Devices (IUCDs), Others)
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Female Contraceptive Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Contraceptive Drugs
    - 10.3.1.2.2. By Device
- 10.3.2. Saudi Arabia Female Contraceptive Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Contraceptive Drugs
    - 10.3.2.2.2. By Device
- 10.3.3. UAE Female Contraceptive Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Contraceptive Drugs
    - 10.3.3.2.2. By Device

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Bayer AG
- 14.1.1. Business Overview
- 14.1.2. Product Offerings
- 14.1.3. Recent Developments
- 14.1.4. Financials (As Reported)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
14.2. Mayer Laboratories Inc
14.3. Pfizer Inc
14.4. Mylan Pharmaceuticals Inc
14.5. Teva Pharmaceutical Industries Ltd
14.6. Organon & Co.
14.7. Agile Therapeutics Inc
14.8. Lupin Pharmaceuticals Inc
14.9. The Female Health Company
14.10. FUJI LATEX CO.,LTD.